AMT
30
4
C
81
-4
DRI
58
-5
CA
36
12
CNX
38
-3
CVX
29
-2
BF.B
33
-2
CVS
43
2
AVY
50
3
AAL
48
-2
AN
50
-2
ADT
50
2
CCL
82
-4
CMA
67
2
BDX
61
2
CHRW
76
-3
CAG
36
2
BK
72
-2
CNP
57
3
AFL
45
-3
AMT
30
4
C
81
-4
DRI
58
-5
CA
36
12
CNX
38
-3
CVX
29
-2
BF.B
33
-2
CVS
43
2
AVY
50
3
AAL
48
-2
AN
50
-2
ADT
50
2
CCL
82
-4
CMA
67
2
BDX
61
2
CHRW
76
-3
CAG
36
2
BK
72
-2
CNP
57
3
AFL
45
-3
Financhill
Back

Principal Financial Group, Inc. Vs. United Therapeutics Corp. Industry Stock Comparison

Buy
53

PFG
Principal Financial Group, Inc.

Last Price:
$89.40
Seasonality Move:
-1.65%
Buy
55

UTHR
United Therapeutics Corp.

Last Price:
$507.08
Seasonality Move:
3.94%
Buy
53
Principal Financial Group, Inc. (PFG) is a Buy

Is Principal Financial Group, Inc. a Buy, Sell or Hold?

  • The current Principal Financial Group, Inc. [PFG] share price is $89.38. The Score for PFG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • PFG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
United Therapeutics Corp. (UTHR) is a Buy

Is United Therapeutics Corp. a Buy, Sell or Hold?

  • The current United Therapeutics Corp. [UTHR] share price is $507.16. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PFG Stock Price Chart

What is Principal Financial Group, Inc.'s stock price today?

  • The Principal Financial Group, Inc. share price today is $89.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PFG is experiencing slight selling pressure.

UTHR Stock Price Chart

What is United Therapeutics Corp.'s stock price today?

  • The United Therapeutics Corp. share price today is $507.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.

PFG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.4 Buy
Relative Strength Index (14 RSI): 60.92 Buy
Chaikin Money Flow: -19554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (84.89 - 89.97) Buy
Bollinger Bands (100): (78.98 - 86.2) Buy

UTHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 139.54 Buy
Relative Strength Index (14 RSI): 61.81 Buy
Chaikin Money Flow: -106696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (477.96 - 506.04) Buy
Bollinger Bands (100): (361.22 - 487.78) Buy

PFG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.37 Buy
20-day SMA: 88.27 Buy
50-day SMA: 84.61 Buy
200-day SMA: 80.51 Buy
8-day EMA: 73.99 Buy
20-day EMA: 45.01 Buy
50-day EMA: 21.82 Buy
200-day EMA: 6.04 Buy

UTHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 510.14 Sell
20-day SMA: 494.95 Buy
50-day SMA: 468.66 Buy
200-day SMA: 362.18 Buy
8-day EMA: 423.25 Buy
20-day EMA: 257.65 Buy
50-day EMA: 124.95 Buy
200-day EMA: 34.59 Buy

Principal Financial Group, Inc. Earnings Growth & PFG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $1.06 per share.

United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.

Principal Financial Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

United Therapeutics Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):